Patents Assigned to Fumedica AG
  • Cytotoxic substance for use in combination with radiotherapy in cancer treatment
    Patent number: 9649298
    Abstract: The present invention provides a substance comprising a preparation of at least one chemotherapeutic or cytotoxic substance for the use in treatment of a disease of a mammalian patient, especially in the treatment of cancer. The invention suggests a symbiotic or synergistic combination of radiotherapy and chemotherapeutic or cytotoxic drug delivery.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: May 16, 2017
    Assignees: Fumedica AG, Universität Bern
    Inventors: Valentin Djonov, Beat Steger
  • CYTOTOXIC SUBSTANCE FOR USE IN COMBINATION WITH RADIOTHERAPY IN CANCER TREATMENT
    Publication number: 20160128983
    Abstract: The present invention provides a substance comprising a preparation of at least one chemotherapeutic or cytotoxic substance for the use in treatment of a disease of a mammalian patient, especially in the treatment of cancer. The invention suggests a symbiotic or synergistic combination of radiotherapy and chemotherapeutic or cytotoxic drug delivery.
    Type: Application
    Filed: June 4, 2014
    Publication date: May 12, 2016
    Applicants: Fumedica AG, Universität Bern
    Inventors: Valentin DJONOV, Beat STEGER